EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Intravitreal Ranibizumab versus Vitreous Lavage for Postoperative Vitreous Hemorrhage in Proliferative Diabetic Retinopathy: A Randomized Controlled Trial

Jiaxing Chi, Xiang Zhang, Zetong Nie, Yue Pan, Wenbo Li, Bojie Hu iD

Drug Design, Development and Therapy · 2026

DOI: 10.2147/dddt.s557400 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Jiaxing Chi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and S…. Hauptthemen laut MEDLINE: Angiogenesis Inhibitors, Diabetic Retinopathy, Ranibizumab, Vitreous Hemorrhage. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiogenesis InhibitorsDiabetic RetinopathyRanibizumabVitreous HemorrhageAdultAgedFemaleHumansMaleMiddle AgedFollow-Up StudiesIntravitreal InjectionsProspective StudiesVisual AcuityVitrectomy

Stichwörter der Autor:innen

intravitreal ranibizumabpostoperative vitreous hemorrhagevitreous lavage

Substanzen

Angiogenesis InhibitorsRanibizumab

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin,…
  • NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, People's Republic of…

ORCID-Profile: Bojie Hu

Zitieren

APA

Chi, J., Zhang, X., Nie, Z., Pan, Y., Li, W., & Hu, B. (2026). Intravitreal Ranibizumab versus Vitreous Lavage for Postoperative Vitreous Hemorrhage in Proliferative Diabetic Retinopathy: A Randomized Controlled Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s557400

Vancouver

Chi J, Zhang X, Nie Z, Pan Y, Li W, Hu B. Intravitreal Ranibizumab versus Vitreous Lavage for Postoperative Vitreous Hemorrhage in Proliferative Diabetic Retinopathy: A Randomized Controlled Trial. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s557400

BibTeX
@article{Chi2026,
  author = {Chi, Jiaxing and Zhang, Xiang and Nie, Zetong and Pan, Yue and Li, Wenbo and Hu, Bojie},
  title = {Intravitreal Ranibizumab versus Vitreous Lavage for Postoperative Vitreous Hemorrhage in Proliferative Diabetic Retinopathy: A Randomized Controlled Trial},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  doi = {10.2147/dddt.s557400}
}
Kostenlos starten →